41.64
price down icon0.46%   -0.1922
after-market After Hours: 41.72 0.0839 +0.20%
loading
Tema Oncology Etf stock is traded at $41.64, with a volume of 22,617. It is down -0.46% in the last 24 hours and up +14.29% over the past month.
See More
Previous Close:
$41.83
Open:
$41.96
24h Volume:
22,617
Relative Volume:
0.80
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+0.74%
1M Performance:
+14.29%
6M Performance:
+20.46%
1Y Performance:
+64.05%
1-Day Range:
Value
$41.34
$42.02
1-Week Range:
Value
$40.50
$42.02
52-Week Range:
Value
$24.77
$42.02

Tema Oncology Etf Stock (CANC) Company Profile

Name
Name
Tema Oncology Etf
Name
Phone
-
Name
Address
-
Name
Employee
0
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
CANC's Discussions on Twitter

Compare CANC vs VTI, SPY, IVV, VB, QQQ

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
CANC icon
CANC
Tema Oncology Etf
41.64 0 0 0 0 0.00
VTI icon
VTI
Vanguard Total Stock Market Etf
371.67 417.53B 0 0 0 0.00
SPY icon
SPY
Spdr S P 500 Etf Trust
751.28 372.57B 0 0 0 0.00
IVV icon
IVV
Ishares Core S P 500 Etf
754.76 253.41B 0 0 0 0.00
VB icon
VB
Vanguard Small Cap Etf
301.66 160.59B 0 0 0 0.00
QQQ icon
QQQ
Invesco Qqq Trust Series 1
722.82 124.43B 0 0 0 0.00

Tema Oncology Etf Stock (CANC) Latest News

pulisher
Jul 01, 2026

(CANC) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily

Jul 01, 2026
pulisher
Jun 30, 2026

CANCTema Oncology ETF Options - Finviz

Jun 30, 2026
pulisher
Jun 23, 2026

TEMA ONCOLOGY ETF (CANC) Stock Chart - ChartMill

Jun 23, 2026
pulisher
Jun 20, 2026

(CANC) Risk Channels and Responsive Allocation - Stock Traders Daily

Jun 20, 2026
pulisher
Jun 19, 2026

Ascentage Pharma Group International (AAPG) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jun 19, 2026
pulisher
Jun 17, 2026

Arcellx Inc (ACLX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Merus NV (MRUS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Pyxis Oncology Inc (PYXS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Helix Acquisition Corp II (HLXB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

CG Oncology Inc (CGON) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jun 17, 2026
pulisher
Jun 09, 2026

(CANC) Movement as an Input in Quant Signal Sets - Stock Traders Daily

Jun 09, 2026
pulisher
May 29, 2026

Liquidity Mapping Around (CANC) Price Events - Stock Traders Daily

May 29, 2026
pulisher
May 20, 2026

CANC Stock Price, Quote & Chart | TEMA ONCOLOGY ETF (NASDAQ:CANC) - ChartMill

May 20, 2026
pulisher
May 18, 2026

Why (CANC) Price Action Is Critical for Tactical Trading - Stock Traders Daily

May 18, 2026
pulisher
May 07, 2026

Understanding Momentum Shifts in (CANC) - Stock Traders Daily

May 07, 2026
pulisher
Apr 26, 2026

Avoiding Lag: Real-Time Signals in (CANC) Movement - Stock Traders Daily

Apr 26, 2026
pulisher
Apr 16, 2026

Tema ETFs Surpasses $2 Billion in AUM in Under Three Years - Yahoo Finance

Apr 16, 2026
pulisher
Apr 14, 2026

Discipline and Rules-Based Execution in CANC Response - Stock Traders Daily

Apr 14, 2026
pulisher
Apr 10, 2026

GNOM, CANC, IBB: Healthcare ETFs Build Long-Term Wealth for Investors - TipRanks

Apr 10, 2026
pulisher
Apr 10, 2026

CANC: I Give A Hold Rating To This ETF That Invests In Cancer-Fighting Stocks - Seeking Alpha

Apr 10, 2026
pulisher
Apr 09, 2026

CANC: First Look At This Addressing Cancer ETF Results In A Hold Rating (Retired Investor) (NASDAQ:CANC) - Seeking Alpha

Apr 09, 2026
pulisher
Apr 03, 2026

Behavioral Patterns of CANC and Institutional Flows - Stock Traders Daily

Apr 03, 2026
pulisher
Mar 23, 2026

(CANC) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily

Mar 23, 2026
pulisher
Mar 20, 2026

Biotech stocks and longevity investing: Trends to track - North Scott Press

Mar 20, 2026
pulisher
Mar 17, 2026

Biotech Stocks & Longevity Investing: Trends to Track - The Motley Fool

Mar 17, 2026
pulisher
Mar 16, 2026

Why Is Cogent Biosciences Stock Surging Monday?Cogent Biosciences (NASDAQ:COGT) - Benzinga

Mar 16, 2026
pulisher
Mar 16, 2026

Land and Houses Asset Management launches LHLONGEVITY, investing in innovative cancer treatment stocks. - moneyandbanking.co.th

Mar 16, 2026
pulisher
Mar 15, 2026

This Investor Built a $56 Million Position in RAPT Last Quarter. It Was Just Acquired for $58 Per Share - AOL.com

Mar 15, 2026
pulisher
Mar 13, 2026

ETFs Investing in Adlai Nortye Ltd. Sponsored ADR Stocks - TradingView

Mar 13, 2026
pulisher
Mar 12, 2026

How (CANC) Movements Inform Risk Allocation Models - Stock Traders Daily

Mar 12, 2026
pulisher
Mar 10, 2026

2 Under-the-Radar Stocks to Buy and Hold - AOL.com

Mar 10, 2026
pulisher
Mar 06, 2026

Healthcare stocks are red-hot. Here are 3 picks from a fund manager up 41% this year. - MSN

Mar 06, 2026
pulisher
Mar 03, 2026

GNOM, CANC, IBB: Use Targeted Healthcare ETFs to Build Wealth - TipRanks

Mar 03, 2026
pulisher
Mar 03, 2026

F/m High Yield 100 ETF (NASDAQ:ZTOP) Shares Down 0.2% – Time to Sell? - Defense World

Mar 03, 2026
pulisher
Mar 01, 2026

Trading Systems Reacting to (CANC) Volatility - Stock Traders Daily

Mar 01, 2026
pulisher
Feb 28, 2026

11 Best Cancer Stocks to Invest In Now - Insider Monkey

Feb 28, 2026
pulisher
Feb 18, 2026

How Tema Oncology Etf (CANC) Affects Rotational Strategy Timing - Stock Traders Daily

Feb 18, 2026
pulisher
Feb 08, 2026

Thrivent Financial for Lutherans Decreases Stake in Tema Oncology ETF $CANC - Defense World

Feb 08, 2026
pulisher
Feb 07, 2026

(CANC) and the Role of Price-Sensitive Allocations - Stock Traders Daily

Feb 07, 2026
pulisher
Jan 31, 2026

2 Stocks That Could Soar This Year - AOL.com

Jan 31, 2026
pulisher
Jan 30, 2026

This Top Dividend Stock Could Achieve a Major Milestone This Year. Is It a Buy? - AOL.com

Jan 30, 2026
pulisher
Jan 27, 2026

Responsive Playbooks and the CANC Inflection - Stock Traders Daily

Jan 27, 2026
pulisher
Jan 16, 2026

Understanding the Setup: (CANC) and Scalable Risk - Stock Traders Daily

Jan 16, 2026
pulisher
Jan 09, 2026

Tema Oncology ETF (NQ: CANC - FinancialContent

Jan 09, 2026
pulisher
Jan 09, 2026

Here's Why Biotech ETFs Are Rallying Hard - Zacks Investment Research

Jan 09, 2026
pulisher
Jan 07, 2026

Los Angeles Daily NewsTema Oncology ETF (Nasdaq:CANC) Stock Quote - FinancialContent

Jan 07, 2026
pulisher
Jan 05, 2026

The Technical Signals Behind (CANC) That Institutions Follow - Stock Traders Daily

Jan 05, 2026
pulisher
Dec 23, 2025

Biotech Market Forecast: Top Trends for Biotech in 2026 - Investing News Network

Dec 23, 2025

Tema Oncology Etf Stock (CANC) Financials Data

There is no financial data for Tema Oncology Etf (CANC). Check out other stocks for more information.

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
VTV VTV
$219.44
price up icon 0.12%
VUG VUG
$86.68
price up icon 1.38%
IJH IJH
$76.42
price up icon 0.43%
EFA EFA
$105.46
price up icon 1.04%
IWF IWF
$123.00
price up icon 1.52%
QQQ QQQ
$722.82
price up icon 1.43%
Cap:     |  Volume (24h):